News

News

Viglya wishes to establish transparent and open communication with its stakeholders. This section offers new and updated information regarding the company and the life science sector.

10.03.2014

AEMPS: Solicitudes de autorización de comercialización de medicamentos de uso humano. Monográfico de bases legales

Sorry, this entry is only available in Español.

LinkedIn1Twitter1Facebook0Google+0tumblr

Comments are closed.

UK MHRA: Pharmacovigilance inspection metrics, 2009 to present
La AEMPS pone a disposición de investigadores del ámbito público la base de datos BIFAP, una potente herramienta para la investigación con medicamentos
UK MHRA: Global health changes and overcoming regulatory challenges was a major part of the MHRA Annual Lecture
UK MHRA assists development of UK manufacturing site for innovative drug-device product
FDA approves treatment for inhalation anthrax
FDA approves new treatment for diabetic retinopathy in patients with diabetic macular edema
ANSM: Préviscan – changement de couleur des comprimés pour limiter le risque d’erreurs médicamenteuses
UK MHRA: Medicines regulator launches call for evidence on previously licensed oral hormonal pregnancy tests
ANSM: Avastin 25mg/ml (bevacizumab): Avis favorable de la commission bénéfice/risque pour une recommandation temporaire d’utilisation (RTU)
ANSM: Sibelium® 10 mg, comprimé sécable (flunarizine) – Réévaluation du rapport bénéfice-risque